MAOB and Parkinson disease: Moreover, activity of MAO-B in the striatum is decreased in mouse model of pre-symptomatic PD (~59% loss of DAergic axons) and returns to the control levels during symptomatic stage, whereas activity of MAO-A is unchanged in the pre-symptomatic PD model and augmented in the symptomatic PD13.